filmov
tv
Apple Watch No-Prick Blood Glucose Monitor Could Change Diabetes Care
Показать описание
Apple Inc. has a moonshot-style project underway that dates back to the Steve Jobs era: noninvasive and continuous blood glucose monitoring.
The goal of this secret endeavor — dubbed E5 — is to measure how much glucose is in someone’s body without needing to prick the skin for blood. After hitting major milestones recently, the company now believes it could eventually bring glucose monitoring to market, according to people familiar with the effort.
If perfected, such a breakthrough would be a boon to diabetics and help cement Apple as a powerhouse in health care. Adding the monitoring system to the Apple Watch, the ultimate goal, would also make that device an essential item for millions of diabetics around the world.
There’s still years of work ahead, but the move could upend a multibillion-dollar industry. Roughly 1 in 10 Americans have diabetes, and they typically rely on a device that pokes the skin for a blood sample. There are also patches from Dexcom Inc. and Abbott Laboratories that are inserted into the skin but need to be replaced about every two weeks.
Apple is taking a different approach, using a chip technology known as silicon photonics and a measurement process called optical absorption spectroscopy. The system uses lasers to emit specific wavelengths of light into an area below the skin where there is interstitial fluid — substances that leak out of capillaries — that can be absorbed by glucose. The light is then reflected back to the sensor in a way that indicates the concentration of glucose. An algorithm then determines a person’s blood glucose level.
Hundreds of engineers are working on the project as part of Apple’s Exploratory Design Group, or XDG, a previously unreported effort akin to X, the moonshot division of Alphabet Inc. It’s one of the most covert initiatives at the famously secretive Apple. Even fewer people are involved in it than the company’s self-driving car undertaking, overseen by the Special Projects Group, or the mixed-reality headset, which is being developed by its Technology Development Group.
The news weighed on shares of diabetes technology companies on Wednesday, with both Dexcom and Abbott falling more than 3% before recovering somewhat. Apple was up 0.4% to $149.06 as of 12:45 p.m. in New York.
A spokesperson for Cupertino, California-based Apple declined to comment.
The company has tested the glucose technology on hundreds of people over the past decade. In human trials, it has used the system with people who don’t know if they’re diabetic, as well as people with prediabetes and Type 2 diabetes. It has compared its own technology to standard tests on blood drawn from veins and samples taken from a prick in the skin, known as capillary blood.
Apple’s system — more than 12 years in the making — is now considered to be at a proof-of-concept stage, said the people, who asked not to be identified because the project is confidential. The company believes the technology is viable but needs to be shrunk down to a more practical size.
Engineers are working to develop a prototype device about the size of an iPhone that can be strapped to a person’s bicep. That would be a significant reduction from an early version of the system that sat atop a table.
One of Apple’s goals for the technology is to create a preventative measure that warns people if they’re prediabetic. They then could make lifestyle changes to try to avoid developing Type 2 diabetes, which occurs when a person’s body doesn’t use insulin properly. Apple’s regulatory team has already held early discussions about getting government approval for the system.
But there’s a reason it’s considered a moonshot goal. Numerous startups — and some of the world’s largest companies — have tried and failed to develop a noninvasive monitoring system. In 2014, Google announced plans to make smart contact lenses that could measure blood glucose through teardrops. It shelved the complex project in 2018.
--------
Bloomberg Quicktake brings you global social video spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
Connect with us on…
The goal of this secret endeavor — dubbed E5 — is to measure how much glucose is in someone’s body without needing to prick the skin for blood. After hitting major milestones recently, the company now believes it could eventually bring glucose monitoring to market, according to people familiar with the effort.
If perfected, such a breakthrough would be a boon to diabetics and help cement Apple as a powerhouse in health care. Adding the monitoring system to the Apple Watch, the ultimate goal, would also make that device an essential item for millions of diabetics around the world.
There’s still years of work ahead, but the move could upend a multibillion-dollar industry. Roughly 1 in 10 Americans have diabetes, and they typically rely on a device that pokes the skin for a blood sample. There are also patches from Dexcom Inc. and Abbott Laboratories that are inserted into the skin but need to be replaced about every two weeks.
Apple is taking a different approach, using a chip technology known as silicon photonics and a measurement process called optical absorption spectroscopy. The system uses lasers to emit specific wavelengths of light into an area below the skin where there is interstitial fluid — substances that leak out of capillaries — that can be absorbed by glucose. The light is then reflected back to the sensor in a way that indicates the concentration of glucose. An algorithm then determines a person’s blood glucose level.
Hundreds of engineers are working on the project as part of Apple’s Exploratory Design Group, or XDG, a previously unreported effort akin to X, the moonshot division of Alphabet Inc. It’s one of the most covert initiatives at the famously secretive Apple. Even fewer people are involved in it than the company’s self-driving car undertaking, overseen by the Special Projects Group, or the mixed-reality headset, which is being developed by its Technology Development Group.
The news weighed on shares of diabetes technology companies on Wednesday, with both Dexcom and Abbott falling more than 3% before recovering somewhat. Apple was up 0.4% to $149.06 as of 12:45 p.m. in New York.
A spokesperson for Cupertino, California-based Apple declined to comment.
The company has tested the glucose technology on hundreds of people over the past decade. In human trials, it has used the system with people who don’t know if they’re diabetic, as well as people with prediabetes and Type 2 diabetes. It has compared its own technology to standard tests on blood drawn from veins and samples taken from a prick in the skin, known as capillary blood.
Apple’s system — more than 12 years in the making — is now considered to be at a proof-of-concept stage, said the people, who asked not to be identified because the project is confidential. The company believes the technology is viable but needs to be shrunk down to a more practical size.
Engineers are working to develop a prototype device about the size of an iPhone that can be strapped to a person’s bicep. That would be a significant reduction from an early version of the system that sat atop a table.
One of Apple’s goals for the technology is to create a preventative measure that warns people if they’re prediabetic. They then could make lifestyle changes to try to avoid developing Type 2 diabetes, which occurs when a person’s body doesn’t use insulin properly. Apple’s regulatory team has already held early discussions about getting government approval for the system.
But there’s a reason it’s considered a moonshot goal. Numerous startups — and some of the world’s largest companies — have tried and failed to develop a noninvasive monitoring system. In 2014, Google announced plans to make smart contact lenses that could measure blood glucose through teardrops. It shelved the complex project in 2018.
--------
Bloomberg Quicktake brings you global social video spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
Connect with us on…
0:00:49
Apple Watch No-Prick Blood Glucose Monitor Could Change Diabetes Care
0:02:30
Apple Makes Headway in Secret Bid to Track Glucose on Watch
0:04:42
The Real Reason the Apple Watch Lacks Glucose Monitoring
0:08:23
I Tried a Non-Invasive Blood Sugar Watch. Miracle or Scam?
0:08:15
Revolutionary Apple Non-Invasive Glucose Monitor - Never Prick Your Finger or Body Again!
0:06:55
Can Apple Watch monitor your blood sugar to prevent diabetes?
0:09:55
Should you TRUST This $30 Non-Invasive Blood Glucose Watch? Putting it to the Test.
0:00:29
No-Prick Glucose Monitoring On Apple Watch Soon #shorts #apple
0:00:05
APPLE'S WATCH AS A NO-PRICK BLOOD GLUCOSE MONITOR 🤷😍✨🔥💫 #shorts
0:00:57
How no-prick blood glucose tracking technology work in apple watch? #shorts #apple #applewatch
0:00:52
Blood Glucose monitoring on Apple Watch?
0:02:04
Upcoming Apple watch may be able to monitor blood glucose without pricking the skin. Details Here
0:01:22
Noninvasive Blood Glucose Testing
0:00:55
Are non-invasive blood glucose monitoring smartwatches accurate & Do they work? | Read descripti...
0:04:31
Apple's no-prick blood glucose monitor reaches milestone
0:00:43
APPLE WATCH CAN TRACK BLOOD SUGAR 🤯🤯🤯
0:00:22
Non-Invasive glucose monitoring device to soon hit the market | FOX 13 Seattle
0:03:28
The Dexcom G6 Can Read Your Blood Sugar Without Any Blood | CNBC
0:00:51
Apple's Secret Project⚡Prick-less Blood Glucose Monitoring on Apple Watch #Shorts
0:01:39
Apple is Reportedly Closer to Adding No-Prick Glucose Monitoring Tech to its Watch
0:08:02
Apple Watch Series X With BLOOD GLUCOSE MONITOR In The Works?
0:00:36
Apple Watch 101: Checking your Blood Oxygen Level #shorts #applewatchseries7
0:01:59
Non-Invasive Glucometer
0:03:17
You NEED a CGM! (Who needs a Continuous Glucose Monitor)
Комментарии